E2F-1 as an anticancer drug target

Oncology Reviews

Volumn 3, Issue 4, 2009, Pages 207-214

  Bertino, Joseph R ^a   Banerjee, Debabrata ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Cancer; E2F 1; MicroRNAs; Retinoblastoma protein

Indexed keywords

4 HYDROXYNONENAL; EUGENOL; LITHIUM CHLORIDE; MICRORNA; MINICHROMOSOME MAINTENANCE PROTEIN 7; OLIGONUCLEOTIDE; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; THYMOQUINONE; TRANSCRIPTION FACTOR E2F1;

ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CANCER RESISTANCE; DRUG RESEARCH; DRUG SENSITIVITY; DRUG TARGETING; GENE ACTIVATION; GENE OVEREXPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; RNA INTERFERENCE; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

EID: 70450225425     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.1007/s12156-009-0028-1     Document Type: Review

References (88)

1. Banerjee D, Bertino JR (2002) E2F and Cancer chemotherapy. In: La Thangue NB, Bandera LR (eds) Targets for cancer chemotherapy: transcription factors and other nuclear proteins, HumanA Press Inc., Totawa, pp 289-298
2. WG Kaelin Jr 2003 E2F-1 as a target: promoter driven suicide and small molecule modulators Cancer Biol Ther 2 SO48 SO54
3. J DeGregori 2002 The genetics of the E2F family of transcription factors: shared functions and unique roles Biochim Biophys Acta 1602 131 150 12020800
4. TC Hallstrom JR Nevins 2009 Balancing the decision of cell proliferation and cell fate Cell Cycle 8 532 535 19182518
5. Polager S, Ginsberg D (2008) E2F1-at the crossroads of life and death. Trends Cell Biol 18:528-535
6. RA Weinberg 1995 The retinoblastoma protein and cell cycle control Cell 81 3 323 330 10.1016/0092-8674(95)90385-2 7736585
7. DG Johnson J Degregori 2006 Putting the Oncogenic and tumor suppressor activities of E2F into context Curr Mol Med 6 731 738 17100599
8. EE Bosco ES Knudsen 2007 RB in breast cancer: at the crossroads of tumorogenesis and treatment Cell Cycle 6 667 671 17361100
9. JW Harbour DC Dean 2000 Rb function in cell-cycle regulation and apoptosis Nat Cell Biol 2 4 E65 E67 10.1038/35008695 10783254 (Pubitemid 30795773)
10. M Classon E Harlow 2002 The retinoblastoma tumor suppressor in development and cancer Nat Rev Cancer 2 12 910 917 10.1038/nrc950 12459729 (Pubitemid 37328892)
11. N Dyson 1998 The regulation of E2F by pRB-family proteins Genes Dev 12 2245 2262 10.1101/gad.12.15.2245 9694791
12. L Di Stefano MR Jensen K Helin 2003 E2F-7, a novel E2F featuring DP independent repression of a subset of E2F-regulated genes EMBO J 22 6289 6298 10.1093/emboj/cdg613 14633988 (Pubitemid 37522586)
13. N Logan L Delavaine A Graham C Reilly J Wilson T Brummelkamp EM Hijmans R Bernards NB LaThangue 2004 E2F-7: a distinctive E2F family member with an unusual organization of DNA binding domains Oncogene 23 5138 5150 10.1038/sj.onc.1207649 15133492 (Pubitemid 38980347)
14. L Endo-Munoz A Dahler N Teaklee D Rickwood M Hazar-Retiham I Abdul-Jabbar S Summerville I Dickenson P Kauer S Paquet-Fifeld N Saunders 2009 E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes : implication for cutaneous squamous cell carcinoma formation Cancer Res 69 1800 1809 10.1158/0008-5472.CAN-08-2725 19223542
15. M Bieda X Xu M Singer R Green PJ Farnham 2006 Unbiased location analysis of E2F-1 binding sites suggests a widespread role for E2F-1 in the human genome Genome Res 6 595 605 10.1101/gr.4887606
16. TC Hallstrom S Mori JR Nevins 2008 An E2F-1 gene expression program that determines the balance between proliferation and cell death Cancer Cell 13 1311 1322 10.1016/j.ccr.2007.11.031 (Pubitemid 350309738)
17. LJ Kong JT Chang AH Bild JR Nevins 2007 Compensation and specificity of function within the E2F family Oncogene 26 321 327 10.1038/sj.onc.1209817 16909124 (Pubitemid 46122822)
18. C Stevens NB La Thangue 2004 The emerging role of E2F-1 in the DNA damage response and checkpoint control DNA Repair (Amst) 3 1071 1079 10.1016/j.dnarep.2004.03.034 (Pubitemid 38997950)
19. A Rabinovich VX Jin R Rabinovich X Xu PJ Farnham 2008 E2F in vivo binding specificity: comparison of consensus versus non-consensus binding sites Genome Res 18 1763 1777 10.1101/gr.080622.108 18836037
20. Y Furukawa N Nihimura Y Furukawa M Satoh H Endo S Iwase M Yamada Y Kano M Nakamura 2002 Apaf-1 is a mediator or E2F-1 induced apoptosis J Biol Chem 277 39730 39768
21. J Wang JG Klijn Y Zhang AM Sieuwerts 2005 Gene expression profiles to predict distant metastasis of lymph node negative primary breast cancer Lancet 365 671 679 15721472
22. J Kikuchi SR Wada H Ando M Nakamura K Ozawa H Furakawa 2007 E2F-6 suppresses growth-associated apoptosis of human hematopoietic progenitor cells by counteracting proapoptotic activity of E2F-1 Stem Cells 10 2439 2447 10.1634/stemcells.2007-0207 (Pubitemid 47582736)
23. TC Hallstrom JR Nevins 2003 Specificity in the activation and control of transcription factor E2F-dependent apoptosis Proc Natl Acad Sci USA 100 10848 10853 10.1073/pnas.1831408100 12954980 (Pubitemid 37140116)
24. R Garzon GA Calin CM Croce 2009 MicroRNAs in cancer Annu Rev Med 60 167 179 10.1146/annurev.med.59.053006.104707 19630570
25. M Chekulaeva W Filipowiczz 2009 Mechanisms of miRNA mediated post-transcriptional regulation in animal cells Curr Opin Cell Biol 21 452 460 10.1016/j.ceb.2009.04.009 19450959
26. LC Spender GJ Inman 2009 TGF-b induces growth arrest in Burkitt lymphoma cells via transcriptional repression of E2F-1 J Biol Chem 284 1435 1442 10.1074/jbc.M808080200 19022773
27. KA O'Donnell EA Wentzel KI Zeller CV Dang JT Mendell 2005 c-MYC-regulated microRNAs modulate E2F expression Nature 435 839 843 10.1038/nature03677 15944709 (Pubitemid 40839736)
28. Y Sylvestre V DeGuire E Querido UK Mukhopadhyay V Bourdau F Major, et al. 2007 An E2F miR-20a autoregulatory feedback loop J Biol Chem 282 2135 2143 10.1074/jbc.M608939200 17135249 (Pubitemid 47076740)
29. F Petrocca A Vechione C Croce 2008 Emerging Role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor B signaling Cancer Res 68 8191 8194 10.1158/0008-5472.CAN-08-1768 18922889
30. F Petrocca R Visone M Rapazzoti-Onelli MH Shah MS Nicoloso I de Martino D Iliopoulos E Pilozzi C-G Liu M Negrini L Caczzini S Volinia H Alder LP Ruco G Baldassarre C Croce 2008 E2F-1 regulated microRNAs impair TGFb-dependent cell-cycle arrest and apoptosis in gastric cancer Cancer Cell 13 272 286 10.1016/j.ccr.2008.02.013 18328430 (Pubitemid 351318375)
31. A Ventura AG Young MM Winslow L Lintault A Meissner SJ Erkeland, et al. 2008 Targeted deletion reveals sequential and overlapping functions of the miR-17 through 92 family of miRNA clusters Cell 132 875 886 10.1016/j.cell.2008. 02.019 18329372 (Pubitemid 351312807)
32. Lee KH, Chen YL, YEH SD, Hsiao M, Lin JT Goan YG, Lu PJ (2009) MicroRNA 330 acts as a tumor suppressor and induces apoptosis of prostate cancer cell through E2F-1 mediated suppression of AKT phosphorylation. Oncogene (epub ahead of print)
33. D Banerjee R Gorlick A Liefshitz, et al. 2000 Levels of E2F1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase Can Res 60 2365 2367
34. C-I Huang D Liu J Nakano H Yokomise M Ueno K Kadota H Wada 2007 E2F1 overexpression correlates with thymidylate synthase and survivin gene expression and tumor proliferation in non small cell lung cancer Clin Can Res 13 6938 6946 10.1158/1078-0432.CCR-07-1539 (Pubitemid 350276873)
35. R Sowers J Toguchida J Qin PA Meyers JH Healey A Huvos D Banerjee JR Bertino R Gorlick 2003 mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma Mol Cancer Ther 2 535 541 12813132
36. VG Gorgoulis P Zacharatos G Mariatos A Kotsinas M Bouda D Kletsas, et al. 2002 Transcriptional factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas J Pathol 198 142 156 10.1002/path.1121 12237873 (Pubitemid 35243872)
37. T Suzuki W Yasui H Yokozaki, et al. 1999 Expression of the E2F family in human gastrointestinal carcinomas Int J Cancer 81 535 538 10.1002/(SICI)1097- 0215(19990517)81:4<535::AID-IJC5>3.0.CO;2-4 10225440 (Pubitemid 29203048)
38. B Eymin S Gazzeri C Brambilla E Brambilla, et al. 2001 Distinct pattern of E2F1 expression in human lung tumours: E2F1 is up-regulated in small cell lung carcinoma Oncogene 20 1678 1687 10.1038/sj.onc.1204242 11313916 (Pubitemid 32368015)
39. SY Zhang SC Liu LF Al-Saleem, et al. 2000 E2F-1: a proliferative marker of breast neoplasia Cancer Epidemiol Biomarkers Prev 9 395 40135 10794484
40. AD Saiz M Olvera S Rezk BA Florentine A McCourty RK Brynes 2002 Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions J Pathol 198 157 162 10.1002/path.1185 12237874 (Pubitemid 35243873)
41. M Iwamoto D Banerjee LG Menon, et al. 2004 Overexpression of E2F1 in lung and liver metastases of human colon cancer is associated with gene amplification Cancer Biol Ther 3 395 399 14726656
42. M Nelson SH Reynolds UNM Rao, et al. 2006 Increased gene copy number of the transcription factor E2F1 in malignant melanoma Cancer Biol Ther 5 407 412 16481740
43. MV Olson DG Johnson H Jiang, et al. 2007 Transgenic E2F1 expression in the mouse brain induces a human like bimodal pattern of tumors Cancer Res 67 4005 4009 10.1158/0008-5472.CAN-06-2973 17483310 (Pubitemid 46815043)
44. E Hernando Z Nahlé G Juan E Diaz-Rodriguez M Alaminos M Hemann L Michel V Mittal W Gerald R Benezra SW Lowe C Cordon-Cardo 2004 Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control Nature 430 797 802 10.1038/nature02820 15306814 (Pubitemid 39071352)
45. MT Pickering TF Kowalik 2006 Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation Oncogene 25 746 755 10.1038/sj.onc.1209103 16186801 (Pubitemid 43214701)
46. H Hao Y Dong MT Bowling JG Gomez-Gutierrez HS Zhou KM McMasters 2007 E2F-1 induces melanoma cell apoptosis via PUMA up-regulation and Bax translocation BMC Cancer 7 24 10.1186/1471-2407-7-24 17263886 (Pubitemid 46306411)
47. R Gorlick R Metzger KD Danenberg, et al. 1998 Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma J Clin Oncol 16 1465 1469 9552053
48. SY Zhang S-C Shao DG Johnson AJP Klein-Szanto 2000 E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines Cancer Res 60 5972 5976 11085515
49. S-O Yoon S Shin AM Mercurio 2006 Ras stimulation of E2F activity and a consequent E2F regulation of Integrin α6β4 promote invasion of breast carcinoma cells Cancer Res 66 6288 6295 10.1158/0008-5472.CAN-06-0826 16778205
50. D Banerjee B Schnieders JZ Fu D Adhikari SC Zhao JR Bertino 1998 Role of E2F-1 in chemosensitivity Cancer Res 58 4292 4296 9766655
51. HJ Lenz CG Leichman KD Danenberg, et al. 1996 Thymidylate synthase m RNA level in adenocarcinoma of the stomach: A predictor of primary tumor response and overall survival J Clin Oncol 14 176 182 8558194
52. L Leichman HJ Lenz CG Leichman, et al. 1997 Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal response and resistance to protracted infusion of fluorouracil and weekly leucovorin J Clin Oncol 41-15 3223 3229
53. PG Johnston HJ Lenz CG Leichman, et al. 1995 Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors Cancer Res 55 1407 1412 7882343
54. HJ Lenz K Hayashi D Salonga, et al. 1998 p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival Clin Cancer Res 4 1243 1250 9607583
55. C Aschele D Debernardis S Casazza, et al. 1999 Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy J Clin Oncol 17 1760 1767 10561213
56. K Hofland BO Peterson J Falck K Helin PB Jensen M Schested 2000 Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex Clin Can Res. 6 1488 1497
57. C Gomez-Manzano MG Lemoine M Hu, et al. 2001 Adenovirally mediated transfer of E2F1 potentiates chemosensitivity of human glioma cells to temozolomide and BCNU Int J Oncol 19 359 365 11445852
58. YB Dong HL Yang MJ Elliot KM McMasters 2002 Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors Cancer Res 62 1776 1783 11912154
59. AJ Russo PG Magro Z Hu, et al. 2006 E2F-1 Overexpression in U2OS Cells Increases Cyclin B1 Levels and cdc2 Kinase Activity and Sensitizes Cells to Antimitotic Agents Cancer Res 66 7253 7260 10.1158/0008-5472.CAN-05-3725 16849574 (Pubitemid 44197706)
60. C Zheng Z Ren H Wang, et al. 2009 E2F1 induces tumor cell survival via Nucelar Factor kB- dependent induction of EGR1 transcription in prostate cancer cells Can Res 69 2324 2331 10.1158/0008-5472.CAN-08-4113
61. MM Alonso R Alemany J Fueyo Gomez-Manzano 2008 E2F-1 in gliomas: aparadigm of oncogene addiction Cancer Lett 263 157 163 10.1016/j.canlet.2008. 02.001 18334281
62. Y Ma WD Cress EB Haura 2003 Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1 Mol Can Ther 2 1 73 81
63. R Croxton Y Ma L Song EB Haura WD Cress 2002 Direct repression of the Mcl-1 promoter by E2F-1 Oncogene 21 1359 1369 10.1038/sj.onc.1205157 11857079
64. L Wu C Timmers B Maiti, et al. 2001 The E2F1-3 transcription factors are essential for cell proliferation Nature 414 457 462 10.1038/35106593 11719808 (Pubitemid 34173728)
65. JD Stendor J Frasor B Komm, et al. 2007 Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation Mol Endocrinol 21 9 2112 2123 10.1210/me.2006-0474 (epub 2007 Jun 5) (Pubitemid 47347376)
66. Y Goto R Hayashi D Kang K Yoshida 2006 Acute loss of transcription factor E2F1 induces mitochondrial biogenesis in HeLa cells J Cell Physiol 209 3 923 934 10.1002/jcp.20802 16972274 (Pubitemid 44665714)
67. Y Jiang HI Saavedra MP Holloway G Leone RA Altura 2004 Aberrant regulation of survivin by the RB/E2F family of proteins J Biol Chem 279 40511 40520 10.1074/jbc.M404496200 15271987 (Pubitemid 39287642)
68. J Fan JR Bertino 1997 Functional Roles of E2F in cell cycle regulation Oncogene 14 1191 1200 10.1038/sj.onc.1200940 9121768
69. CL Wu M Classon N Dyson E Harlow 1996 Expression of dominant negative mutant DP-1 blocks cell cycle progression in G1 Mol Cell Biol 16 7 3698 3706 8668186
70. X Xu M Bieda VX Jin A Rabinovich MJ Oberley R Green PJ Farnham 2007 A comprehensive Chip-chip analysis of E2F-1, E2F-4, and E2F-6, in normal and tumor cells reveals interchangeable roles of E2F family members Genome Res 11 1550 1561 10.1101/gr.6783507 (Pubitemid 350074851)
71. N Tomita M Horiuchi S Tomita, et al. 1998 An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro Am J Physiol 275 2 Pt 2 F278 F284 9691019
72. Y Maeshima N Kashihara T Yasuda H Sugiyama T Sekikawa K Okamoto K kanao Y Watanabe YS Kanwar H Kakino 1998 Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo J Clin Invest 101 2589 2597 10.1172/JCI429 9616230
73. R Morishita GH Gibbons M Horiuchi KE Ellison M Nakama L Zhang Y Kaneda T Ogihara VJ Dzau 1996 A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo Proc Natl Acad Sci USA 92 6855 6859
74. JD Ahn CH Kim J Magae YH Kim HJ Kim KK Park TK Lee YC Chang 2003 E2F decoy oligonucleotides effectively inhibit growth of human tumor cells Biochem Biophys Res Cummun 310 1048 1053 10.1016/j.bbrc.2003.09.124 (Pubitemid 37237642)
75. X Gao Q Sun H Lin Y Bai B Yang H Wang, et al. 2006 A single decoy oligonucleotide targeting multiple oncoproteins produces strong anticancer effects Mol Pharmacol 70 1621 1629 10.1124/mol.106.024273 16936227 (Pubitemid 44776421)
76. MJ Mann MS Conte 2003 Transcription factor decoys for the prevention of vein bypass graft failure Am J Cardiovasc Drugs 3 79 85 10.2165/00129784- 200303020-00001 14727934 (Pubitemid 36665528)
77. AW Hoel MS Conte 2007 Edifoligide: a transcription factor decoy to modulate smooth muscle cell proliferation in Vein bypass Cardiovasc Drug Rev 25 221 234 10.1111/j.1527-3466.2007.00020.x 17919257 (Pubitemid 47547466)
78. L Bandera R Girling N Lathangue 1997 Apoptosis induced in mammalian cells by small peptides that functionally antagonize the Rb regulated E2F transcription factor Nat Biotechnol 15 896 901 10.1038/nbt0997-896
79. E Fabbrizzio L Cam J Polanski M kaczorek N Lamb R Brent C Sardet 1999 Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity Oncogene 18 4357 4363 10.1038/sj.onc.1202825 (Pubitemid 29392376)
80. Y Ma CA Kurtyka S Boyapalle SS Sung K Lawrence W Guida WD Cress 2008 A small molecule E2F inhibitor blocks growth in a melanoma culture model Cancer Res 68 6292 6299 10.1158/0008-5472.CAN-08-0121 18676853
81. S Montigiani R Muller RE Kontermann 2003 Inhibition of cell proliferation and induction of apoptosis by novel tetravalent peptides inhibiting DNA binding of E2F Oncogene 22 4943 4952 10.1038/sj.onc.1206495 12902977 (Pubitemid 37026393)
82. J Ishizaki J Nevins BA Sullinger 1996 Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function Nature Med 2 1386 1389 10.1038/nm1296-1386 8946842 (Pubitemid 26401746)
83. X Xie D Banerjee T Budak-Alpdogan JR Bertino 2009 A novel E2F-DNA binding inhibiting peptide that induces apoptosis and synergizes with E2F-1 downstream targets in prostate cancer cells Proc Am Assoc Cancer Res 50 1319
84. Y Xie Y Yin L Li Q Xiao 2009 Short interfering RNA directed against the E2F-1 gene suppressing gastric cancer progression in vitro Oncol Rep 21 5 1345 1353 19360313
85. AO Kaseb C Kannagi D Chen A Sivanandam S Tejwani M manon Q Pind Dou G Prem-Veer Reddy 2007 Androgen Receptor and E2F-1-targeted thymoquinone therapy for hormone refractory prostate cancer Cancer Res 67 7782 7788 10.1158/0008-5472.CAN-07-1483 17699783 (Pubitemid 47281372)
86. A Sun I Shanmugam J Song PF Terranova JB Thrasher B Li 2007 Lithium suppresses cell proliferation by interrupting E2F-DNA interaction, subsequently reducing S-phase gene expression in prostate cancer Prostate 67 976 988 10.1002/pros.20586 17440966 (Pubitemid 46828931)
87. R Ghosh N Nadiminty JE Fitzpatrick WL Alworth TJ Slaga AP Kumar 2005 Eugenol causes melanoma growth suppression through inhibition of E2F-1 transcriptional activity J Biol Chem 280 5812 5819 10.1074/jbc.M411429200 15574415 (Pubitemid 40280062)
88. G Barrera S Pizzimenti MU Dianzani 2004 4-hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway Free Radic Biol Med 37 597 606 10.1016/j.freeradbiomed.2004.05.023 15288118 (Pubitemid 38993508)